Supply Issues Vygon UK Ltd Stopcock Sterile FVK157 (ICN 3234)

• The supply issue with Stopcock Sterile products from Vygon UK Ltd is continuing.
• One product remains suspended and unavailable to order:
  • FVK157 – Stopcock sterile 3 way 2 female and 1 male luer lock.
• One product remains affected in total.
• A potential indirect alternative product is available to order through our online catalogue for the affected product. However, some of these products may also become subject to intermittent supply with the increase in demand.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternative.
• The supply issue is now anticipated to be resolved by 7 April 2026.

Change:

• The supplier Vygon UK Ltd has informed us of a supply issue with its Stopcock Sterile products.
• One product code is affected:
  • FVK157 – Stopcock sterile 3 way 2 female ands 1 male luer lock.
• The supply issue is due to supplier manufacturing issues.

Impact:

• The affected product is currently suspended and unavailable to order.
• A potential indirect alternative product is available to order through our online catalogue:
  • FVK156 – Stopcock sterile lipid resistant 3 way 2 female and 1 male luer lock color coded lipid resistant.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
• The supply issue is anticipated to be resolved by 27 March 2026.

Next Steps:              

• Customers are advised to log into our website to view the potential indirect alternative products.
• The continuing supply issue is being monitored in conjunction with the supplier, and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.